Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

Chaturvedi N(2001)Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold Kidney Int 60 219-227

Bandinelli S(2001)Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes Diabetes Care 24 284-289

Mangili R(2000)C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 836-843

Chaturvedi N(1999)Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation Diabetologia 42 351-357

Sjoelie AK(1995)Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 96 1395-1403

Porta M(1994)Microvascular and acute complications in IDDM patients: the EURODIAB IDDM complications study Diabetologia 37 278-285

Ridker PM(2001)Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes Diabetes Care 24 2071-2077

Hennekens CH(1995)Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study Diabetologia 38 437-444

Buring JE(1996)Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group Diabetes Care 19 689-697

Rifai N(1998)Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus Thromb Haemost 80 52-57

Chaturvedi N(2001)Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold Kidney Int 60 219-227

Bandinelli S(2001)Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes Diabetes Care 24 284-289

Mangili R(2000)C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 836-843

Chaturvedi N(1999)Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation Diabetologia 42 351-357

Sjoelie AK(1995)Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 96 1395-1403

Porta M(1994)Microvascular and acute complications in IDDM patients: the EURODIAB IDDM complications study Diabetologia 37 278-285

Ridker PM(2001)Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes Diabetes Care 24 2071-2077

Hennekens CH(1995)Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study Diabetologia 38 437-444

Buring JE(1996)Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group Diabetes Care 19 689-697

Rifai N(1998)Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus Thromb Haemost 80 52-57